Skip to content

Proprioception and Sensorimotor Control in Hereditary Sensory and Autonomic Neuropathy

Proprioception and Sensorimotor Control in Hereditary Sensory and Autonomic Neuropathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02876939
Enrollment
16
Registered
2016-08-24
Start date
2016-11-30
Completion date
2019-07-25
Last updated
2020-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atunomic Neuropathy

Keywords

Hereditary Sensory Neuropathy, Autonomic Neuropathy, Familial Dysautonomia, proprioception, motor control, sensory nervous system., HSAN III, IKBKAP gene mutation

Brief summary

This project comprises three sets of physiological studies - testing eight specific hypotheses - that will contribute new knowledge on proprioception and motor control in a genetic disorder that affects specific components of the sensory nervous system. I: To investigate the neurophysiological basis for disturbed motor control in Hereditary sensory and autonomic neuropathy (HSAN) III II: To investigate the effects of enhancing cutaneous feedback on motor control in HSAN III III: To investigate the cortical representation of proprioceptive inputs in HSAN III

Detailed description

HSAN III patients (n=15) and healthy control subjects (n=15) will lay supine on an MRI bed and a tungsten microelectrode inserted percutaneously into a muscle or cutaneous fascicle of the right common peroneal nerve at the fibular head, according to standard techniques employed by Prof Macefield. Neural activity will be acquired, RMS-processed (200 ms) and analysed on computer. The subject's head will be tightly enclosed in a standard clinical 32-channel SENSE head coil and headphones will be provided to minimize noise and to allow communication with the subject. The subject will be placed in the bore of a 3T whole-body scanner for 60-90 minutes.

Interventions

OTHERkinesiology tape around the hip, knee and ankle joints

We will also demonstrate that taping the skin increases the central representation of cutaneous afferent input in HSAN III.

OTHERNo kinesiology tape around the hip, knee and ankle joints

Investigators will demonstrate that taping the skin increases the central representation of cutaneous afferent input in HSAN III.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Confirmed genetic diagnosis of HSAN III will be recruited from the Dysautonomia Center at NYU

Exclusion criteria

* homeless * active drug or alcohol dependence * evidence of neurological disorder or diabetes * exposure to neurotoxic drugs that in the investigator's opinion may compromise results * Pregnant women

Design outcomes

Primary

MeasureTime frame
Measurement of gait in HSAN III120 Minutes

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026